Home›People›Erin Lavelle
EL

Erin Lavelle

Director at Aviceda Therapeutics.

Director
Updated Nov 2, 2026·Latest SEC filing Jan 13, 2025·Suggest an edit

About Erin Lavelle

Erin Lavelle is a director at Aviceda Therapeutics.

Erin Lavelle first appears on SEC filings in 2024.

Experience

This experience comes from SEC filings. The years are when the filings name Erin Lavelle in the role, so the role may have started earlier or lasted longer.

Aviceda Therapeutics, Inc.
Director
2024 – 2025 · Cambridge, MA

Key Colleagues at Startups

The people Erin Lavelle works with at each company, as listed on that company's latest Form D.

Aviceda Therapeutics, Inc. · Form D/A, Jan 13, 2025
DC
David Callanan
Executive officer
NT
MG
Mohamed Genead
Executive officer and director
MT
Michael Tolentino
Executive officer and director
CA
TH
Tarek Hassan
Executive officer
DG
David Guyer
Director
DK
Derek Kunimoto
Member of Office of CEO & President
JW
Jay Woods
Director

Sources

  1. SECAviceda Therapeutics, Inc. Form D/A, filed Jan 13, 2025